Clinical Trials Logo

Suicidality clinical trials

View clinical trials related to Suicidality.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05541406 Recruiting - Depression Clinical Trials

Efficacy of a Multi-level School Intervention for LGBTQ Youth

Start date: September 14, 2022
Phase: N/A
Study type: Interventional

Efficacy of a Multi-level School Intervention for LGBTQ Youth

NCT ID: NCT05177146 Recruiting - Suicidality Clinical Trials

Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression

DEEPP
Start date: May 4, 2022
Phase: N/A
Study type: Interventional

Bipolar disorder is characterized by manic episodes and episodes of extreme depressive feelings, also known as bipolar depression (BD). Although clinical data does not suggest significant differences in the severity of depressive symptoms between bipolar and unipolar depression, patients with BD are found to be more likely to experience suicidal ideation and suicide attempts. Innovative treatments for suicidality in patients with BD are needed to address tolerability and slow effect limitations of current interventions. Using an open label pilot study, this trial aims to examine the effect of Intravenous (IV) ketamine treatment on acute suicidality in patients with BD. Moreover, the study aims to explore the neurophysiological mechanisms of ketamine's action directly from the cortex in patients with BD, in order to understand the biological mechanism underlying ketamine's therapeutic action.

NCT ID: NCT01046851 Recruiting - Suicidality Clinical Trials

A Study of Nopan Treatment of Acute Suicidality

Start date: September 2008
Phase: Phase 3
Study type: Interventional

Anecdotal evidence and several clinical studies found the mixed opioid agonist-antagonist Nopan to be an effective antidepressant with a rapid onset of action. It is therefore hypothesized that Nopan may be a novel and quick-acting treatment for acute suicidality. Depression, suicidality, and overall functioning will be assessed before, during and after a four-week Nopan/placebo trial. It is hypothesized that subjects who receive the active drug will show rapid improvements in objective and subjective measures of these variables.